Precision Epigenomics, Inc.
Publicly observedTucson, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Tucson | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Precision Epigenomics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | Q7F7RURVX196 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Feb 2025Publicly observed
NIH SBIR/STTR award: Development of a Molecular Assay to Diagnose Malignant Pleural Effusions
USD 70,000.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 Aug 2024Publicly observed
NIH SBIR/STTR award: Development of a Molecular Assay to Diagnose Malignant Pleural Effusions
USD 1,041,709.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.